Kewaunee Scientific Corp. /DE/ (KEQU) intrinsic value & 10-year financials
Kewaunee Scientific Corp. /DE/ (KEQU) has a Graham intrinsic value of $105.14 per share. At $32.92 on Oct 17, 2026, the stock trades 69% below that value. Over the last 10 fiscal years revenue grew 7.2% a year to $240.5M, with an average return on invested capital of 9.9%.
- Graham intrinsic value
- $105.14
- Share price (Oct 17, 2026)
- $32.92
- Price vs Graham value
- 69% below
- Market cap
- $98.1M
- Revenue (FY2025)
- $240.5M
- Revenue growth (10-yr CAGR)
- 7.2%
- ROIC (10-yr avg)
- 9.9%
- Free cash flow (FY2025)
- $12.6M
KEQU 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $240.5M | $11.4M | $3.83 | $12.6M | 7.4% | 20.3% |
| FY2024 | $203.8M | $18.8M | $6.38 | $15.2M | 9.0% | 45.4% |
| FY2023 | $219.5M | $738.0K | $0.25 | -$7.9M | 2.4% | 6.8% |
| FY2022 | $168.9M | -$6.1M | -$2.20 | -$9.8M | -1.5% | -5.8% |
| FY2021 | $147.5M | -$3.7M | -$1.33 | -$1.5M | -0.9% | -2.8% |
| FY2020 | $147.5M | -$4.7M | -$1.70 | $1.7M | -1.6% | -6.0% |
| FY2019 | $146.6M | $1.5M | $0.55 | -$1.7M | 1.4% | 4.3% |
| FY2018 | $158.1M | $5.2M | $1.87 | -$212.0K | 5.7% | 14.0% |
| FY2017 | $138.6M | $4.5M | $1.66 | $9.1M | 4.7% | 12.6% |
| FY2016 | $128.6M | $3.8M | $1.42 | $5.1M | 4.4% | 10.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
KEWAUNEE SCIENTIFIC CORP /DE/ has demonstrated mature, steady growth, with revenue compounding at 7.2% annually over the past decade.
KEWAUNEE SCIENTIFIC CORP /DE/ returns on capital have been average, hovering around 9.9% ROIC over the decade.
Over the decade, KEWAUNEE SCIENTIFIC CORP /DE/ shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, KEWAUNEE SCIENTIFIC CORP /DE/ is modeled at 11.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $105.14 per share.